Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Shares Issued (2023 - 2025)

Envoy Medical's Shares Issued history spans 3 years, with the latest figure at $2.3 million for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $2.3 million; the TTM value through Sep 2025 reached $2.4 million, down 79.04%, while the annual FY2024 figure was $1.8 million, 81.85% down from the prior year.
  • Shares Issued for Q3 2025 was $2.3 million at Envoy Medical, up from $132000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $9.9 million in Q4 2023 and bottomed at $132000.0 in Q4 2024.
  • The 3-year median for Shares Issued is $2.0 million (2024), against an average of $3.5 million.
  • The largest YoY upside for Shares Issued was 98.67% in 2024 against a maximum downside of 98.67% in 2024.
  • A 3-year view of Shares Issued shows it stood at $9.9 million in 2023, then crashed by 98.67% to $132000.0 in 2024, then surged by 1639.39% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Shares Issued are $2.3 million (Q3 2025), $132000.0 (Q4 2024), and $1.7 million (Q1 2024).